Dear Activators
Dear, a dual receptor for endothelin-1 and angiotensin II, emerges as a critical player in G protein-coupled receptor signaling pathways, particularly located in the plasma membrane. Its functional significance lies in enabling cellular responses to angiotensin II and endothelin-1, key players in cardiovascular homeostasis and vascular tone regulation. By possessing both angiotensin type II receptor activity and endothelin receptor activity, Dear integrates signals from two potent vasoactive peptides, allowing for nuanced cellular responses.
The activation of Dear is intricately regulated by a repertoire of chemicals that either directly engage with the receptor or modulate the signaling pathways associated with its function. Substances like Losartan and Bosentan act as indirect activators by disrupting angiotensin II and endothelin signaling, respectively. On the other hand, molecules like Angiotensin II and Endothelin-1 directly interact with Dear, initiating cascades of events that lead to its up-regulation. This dual nature of activation, involving both direct ligand-receptor interactions and modulation of signaling pathways, underscores the versatility and adaptability of Dear in responding to various extracellular cues. Understanding these activation mechanisms not only sheds light on Dear's functional intricacies but also provides a foundation for exploring its role in cardiovascular physiology and potential implications in related pathologies.
User
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan, an angiotensin II receptor blocker, disrupts the angiotensin type II receptor signaling pathway, indirectly activating Dear. By inhibiting angiotensin II binding, it triggers downstream responses, leading to the up-regulation of Dear. | ||||||
Bosentan | 147536-97-8 | sc-210957 | 10 mg | $195.00 | 3 | |
Bosentan, an endothelin receptor antagonist, influences the endothelin receptor activity, indirectly promoting Dear. By blocking endothelin signaling, it modulates the cellular environment, contributing to the activation of Dear. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II, a peptide hormone, directly activates Dear by binding to angiotensin type II receptors. It initiates G protein-coupled receptor signaling, inducing a cascade of events that result in the up-regulation of Dear. | ||||||
Candesartan | 139481-59-7 | sc-217825 sc-217825B sc-217825A | 10 mg 100 mg 1 g | $47.00 $94.00 $151.00 | 6 | |
Candesartan, an angiotensin II receptor antagonist, indirectly activates Dear by disrupting angiotensin type II receptor signaling. Through this inhibition, it prompts cellular responses that culminate in the up-regulation of Dear. | ||||||
Sitaxsentan Sodium | 210421-74-2 | sc-215857 | 10 mg | $640.00 | ||
Sitaxentan, an endothelin receptor antagonist, indirectly influences Dear activation by modulating endothelin receptor activity. Its action disrupts the normal signaling cascade, leading to the increased expression of Dear. | ||||||
Ambrisentan | 177036-94-1 | sc-207276 | 5 mg | $348.00 | ||
Ambrisentan, an endothelin receptor antagonist, influences endothelin receptor activity, indirectly promoting Dear. Its impact on the receptor signaling cascade leads to the modulation of Dear expression and enhanced cellular responses. | ||||||
Angiotensin fragment 1-7 acetate salt | 51833-78-4 | sc-319824 | 1 mg | $84.00 | 1 | |
Angiotensin (1-7), a biologically active peptide, directly engages angiotensin receptors, activating Dear. Its binding to the receptor initiates intracellular signaling, resulting in the up-regulation of Dear and subsequent modulation of cellular functions. | ||||||
Olmesartan Medoxomil | 144689-63-4 | sc-219482 sc-219482A | 10 mg 100 mg | $60.00 $186.00 | ||
Olmesartan, an angiotensin II receptor antagonist, indirectly activates Dear by disrupting angiotensin type II receptor signaling. Through its inhibitory action, it prompts cellular responses that culminate in the up-regulation of Dear. | ||||||
IRL-2500 | 169545-27-1 | sc-204018 sc-204018A | 10 mg 50 mg | $270.00 $1040.00 | ||
IRL-2500, an endothelin receptor antagonist, indirectly influences Dear activation by modulating endothelin receptor activity. Its action disrupts the normal signaling cascade, leading to the increased expression of Dear. | ||||||